(MedPage Today) — The FDA has taken a cautious and scientific evidence-based approach to regulating mifepristone (Mifeprex) over the years, contrary to what the Trump administration has alleged, an analysis of agency documents found.
In a qualitative…
Source link : https://www.medpagetoday.com/obgyn/abortion/119380
Author :
Publish date : 2026-01-12 17:03:00
Copyright for syndicated content belongs to the linked Source.
